Danish Company Builds Vertical Cultivation System for Cannabis with Heliospectra’s LED Lighting System

Heliospectra’s horticultural lighting and control system has been selected by a Danish company, Cannabis Pharm for their new production facility. The Danish company has ordered Heliospectra’s ELIXIA LED lighting solutions and HelioCORE™ light control software to fully automate the lighting environment and provide highest quality pharmaceutical products.

(Image: Heliospectra)

Cannabis Pharm is currently constructing a new high-density vertical cultivation system in Randers, Denmark. The company has entered partnership with Heliospectra and their Canadian partner Montel to combine centralized LED light management strategies and state-of-the-art mobile racks for a total solution to optimize plant quality and maximize production and business performance.

The shipment of the orders will take place during the first quarter of 2019 and be visible in the accounts during the fourth quarter of 2018 and first quarter of 2019.

“Denmark is quickly becoming one of Europe’s biggest medical cannabis producers. As the European market continues to expand the medical cannabis industry, standardized high-quality products are keys to success. During its’ life cycle, the cannabis plant goes through several different growth stages, all with different requirements on environmental factors such as light levels and spectrum. Our intelligent ELIXIA LED grow light solution and helioCORE control software provide growers with the ability to automatically adjust the light with respect to the plants’ needs, as well as the environmental prerequisites, thereby optimizing the growing condition for the crop and increases the energy efficiency of the growth”, said Ali Ahmadian, CEO of Heliospectra.

According to Heliospectra, the trend to legalize medical cannabis around the world has created a drive for expertise within the field. The company has been working with several institutes and companies to expand the knowledge within the industry. Since this year, Heliospectra has reported collaborations with research institutions for medicinal cannabis growth from Canada, Australia, Macedonia and Denmark.

Disclaimers of Warranties
1. The website does not warrant the following:
1.1 The services from the website meets your requirement;
1.2 The accuracy, completeness, or timeliness of the service;
1.3 The accuracy, reliability of conclusions drawn from using the service;
1.4 The accuracy, completeness, or timeliness, or security of any information that you download from the website
2. The services provided by the website is intended for your reference only. The website shall be not be responsible for investment decisions, damages, or other losses resulting from use of the website or the information contained therein

Proprietary Rights

You may not reproduce, modify, create derivative works from, display, perform, publish, distribute, disseminate, broadcast or circulate to any third party, any materials contained on the services without the express prior written consent of the website or its legal owner.